Correlation Between Fubon MSCI and SciVision Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and SciVision Biotech, you can compare the effects of market volatilities on Fubon MSCI and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and SciVision Biotech.

Diversification Opportunities for Fubon MSCI and SciVision Biotech

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fubon and SciVision is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and SciVision Biotech go up and down completely randomly.

Pair Corralation between Fubon MSCI and SciVision Biotech

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 0.48 times more return on investment than SciVision Biotech. However, Fubon MSCI Taiwan is 2.08 times less risky than SciVision Biotech. It trades about -0.07 of its potential returns per unit of risk. SciVision Biotech is currently generating about -0.19 per unit of risk. If you would invest  14,075  in Fubon MSCI Taiwan on August 30, 2024 and sell it today you would lose (260.00) from holding Fubon MSCI Taiwan or give up 1.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Fubon MSCI Taiwan  vs.  SciVision Biotech

 Performance 
       Timeline  
Fubon MSCI Taiwan 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Fubon MSCI is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
SciVision Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Fubon MSCI and SciVision Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fubon MSCI and SciVision Biotech

The main advantage of trading using opposite Fubon MSCI and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.
The idea behind Fubon MSCI Taiwan and SciVision Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like